373 related articles for article (PubMed ID: 25601544)
41. YAP1 is essential for osteoclastogenesis through a TEADs-dependent mechanism.
Zhao L; Guan H; Song C; Wang Y; Liu C; Cai C; Zhu H; Liu H; Zhao L; Xiao J
Bone; 2018 May; 110():177-186. PubMed ID: 29432919
[TBL] [Abstract][Full Text] [Related]
42. The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer.
Song S; Honjo S; Jin J; Chang SS; Scott AW; Chen Q; Kalhor N; Correa AM; Hofstetter WL; Albarracin CT; Wu TT; Johnson RL; Hung MC; Ajani JA
Clin Cancer Res; 2015 Jun; 21(11):2580-90. PubMed ID: 25739674
[TBL] [Abstract][Full Text] [Related]
43. Mechanism of Ca2+-mediated regulation of NDR protein kinase through autophosphorylation and phosphorylation by an upstream kinase.
Tamaskovic R; Bichsel SJ; Rogniaux H; Stegert MR; Hemmings BA
J Biol Chem; 2003 Feb; 278(9):6710-8. PubMed ID: 12493777
[TBL] [Abstract][Full Text] [Related]
44. Aberrant activation, nuclear localization, and phosphorylation of Yes-associated protein-1 in the embryonic kidney and Wilms tumor.
Murphy AJ; Pierce J; de Caestecker C; Libes J; Neblett D; de Caestecker M; Perantoni AO; Tanigawa S; Anderson JR; Dome JS; Das A; Carroll TJ; Lovvorn HN
Pediatr Blood Cancer; 2014 Feb; 61(2):198-205. PubMed ID: 24115727
[TBL] [Abstract][Full Text] [Related]
45. YAP1-Mediated Suppression of USP31 Enhances NFκB Activity to Promote Sarcomagenesis.
Ye S; Lawlor MA; Rivera-Reyes A; Egolf S; Chor S; Pak K; Ciotti GE; Lee AC; Marino GE; Shah J; Niedzwicki D; Weber K; Park PMC; Alam MZ; Grazioli A; Haldar M; Xu M; Perry JA; Qi J; Eisinger-Mathason TSK
Cancer Res; 2018 May; 78(10):2705-2720. PubMed ID: 29490948
[TBL] [Abstract][Full Text] [Related]
46. Cytoplasmatic and Nuclear YAP1 and pYAP1 Staining in Urothelial Bladder Cancer.
Latz S; Umbach T; Goltz D; Kristiansen G; Müller SC; Ellinger J
Urol Int; 2016; 96(1):39-45. PubMed ID: 26287745
[TBL] [Abstract][Full Text] [Related]
47. PKCι regulates nuclear YAP1 localization and ovarian cancer tumorigenesis.
Wang Y; Justilien V; Brennan KI; Jamieson L; Murray NR; Fields AP
Oncogene; 2017 Jan; 36(4):534-545. PubMed ID: 27321186
[TBL] [Abstract][Full Text] [Related]
48. Regulation of NDR protein kinase by hydrophobic motif phosphorylation mediated by the mammalian Ste20-like kinase MST3.
Stegert MR; Hergovich A; Tamaskovic R; Bichsel SJ; Hemmings BA
Mol Cell Biol; 2005 Dec; 25(24):11019-29. PubMed ID: 16314523
[TBL] [Abstract][Full Text] [Related]
49. ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells.
Machado-Neto JA; Lazarini M; Favaro P; Franchi GC; Nowill AE; Saad ST; Traina F
Exp Cell Res; 2014 Jun; 324(2):137-45. PubMed ID: 24726915
[TBL] [Abstract][Full Text] [Related]
50. The Immunoexpression of YAP1 and LATS1 Proteins in Clear Cell Renal Cell Carcinoma: Impact on Patients' Survival.
Godlewski J; Kiezun J; Krazinski BE; Kozielec Z; Wierzbicki PM; Kmiec Z
Biomed Res Int; 2018; 2018():2653623. PubMed ID: 29850494
[TBL] [Abstract][Full Text] [Related]
51. Downstream of human NDR kinases: impacting on c-myc and p21 protein stability to control cell cycle progression.
Cornils H; Kohler RS; Hergovich A; Hemmings BA
Cell Cycle; 2011 Jun; 10(12):1897-904. PubMed ID: 21593588
[TBL] [Abstract][Full Text] [Related]
52. Amotl1 mediates sequestration of the Hippo effector Yap1 downstream of Fat4 to restrict heart growth.
Ragni CV; Diguet N; Le Garrec JF; Novotova M; Resende TP; Pop S; Charon N; Guillemot L; Kitasato L; Badouel C; Dufour A; Olivo-Marin JC; Trouvé A; McNeill H; Meilhac SM
Nat Commun; 2017 Feb; 8():14582. PubMed ID: 28239148
[TBL] [Abstract][Full Text] [Related]
53. The Hippo Pathway Effector YAP1 Regulates Intestinal Epithelial Cell Differentiation.
Fallah S; Beaulieu JF
Cells; 2020 Aug; 9(8):. PubMed ID: 32823612
[TBL] [Abstract][Full Text] [Related]
54. Yap1 is dispensable for self-renewal but required for proper differentiation of mouse embryonic stem (ES) cells.
Chung H; Lee BK; Uprety N; Shen W; Lee J; Kim J
EMBO Rep; 2016 Apr; 17(4):519-29. PubMed ID: 26917425
[TBL] [Abstract][Full Text] [Related]
55. [Expression relationship of Hippo signaling molecules and ovarian germline stem cell markers in the ovarian aging process of women and mice].
Xu J; Cao XP; Tang ZJ; Huang J; Zheng YH; Li J
Sheng Li Xue Bao; 2019 Jun; 71(3):405-414. PubMed ID: 31218331
[TBL] [Abstract][Full Text] [Related]
56. The polycystic ovary syndrome-associated gene Yap1 is regulated by gonadotropins and sex steroid hormones in hyperandrogenism-induced oligo-ovulation in mouse.
Ji SY; Liu XM; Li BT; Zhang YL; Liu HB; Zhang YC; Chen ZJ; Liu J; Fan HY
Mol Hum Reprod; 2017 Oct; 23(10):698-707. PubMed ID: 28961951
[TBL] [Abstract][Full Text] [Related]
57. Regulation of NDR2 protein kinase by multi-site phosphorylation and the S100B calcium-binding protein.
Stegert MR; Tamaskovic R; Bichsel SJ; Hergovich A; Hemmings BA
J Biol Chem; 2004 May; 279(22):23806-12. PubMed ID: 15037617
[TBL] [Abstract][Full Text] [Related]
58. Nuclear Dbf2-related protein kinases (NDRs) in isolated cardiac myocytes and the myocardium: activation by cellular stresses and by phosphoprotein serine-/threonine-phosphatase inhibitors.
Fuller SJ; Pikkarainen S; Tham el L; Cullingford TE; Molkentin JD; Cornils H; Hergovich A; Hemmings BA; Clerk A; Sugden PH
Cell Signal; 2008 Aug; 20(8):1564-77. PubMed ID: 18555663
[TBL] [Abstract][Full Text] [Related]
59. CLDN6 promotes tumor progression through the YAP1-snail1 axis in gastric cancer.
Yu S; Zhang Y; Li Q; Zhang Z; Zhao G; Xu J
Cell Death Dis; 2019 Dec; 10(12):949. PubMed ID: 31827075
[TBL] [Abstract][Full Text] [Related]
60. Yap1 acts downstream of α-catenin to control epidermal proliferation.
Schlegelmilch K; Mohseni M; Kirak O; Pruszak J; Rodriguez JR; Zhou D; Kreger BT; Vasioukhin V; Avruch J; Brummelkamp TR; Camargo FD
Cell; 2011 Mar; 144(5):782-95. PubMed ID: 21376238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]